Global Biotechnology Contract Manufacturing Market Assessment, By Platform Type [Mammalian-based, Microbial-based], By Product Type [Monoclonal Antibodies, Recombinant Protein, Vaccine, Insulin, Growth Factor, Interferons, Others], By Application Type [Clinical, Commercial], By Therapeutic Area Type [Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others], By Region, Opportunities and Forecast, 2017-2031F

Global biotechnology contract manufacturing market is projected to witness a CAGR of 8.5% during the forecast period 2024-2031, growing from USD 17.69 billion in 2023 to USD 33.97 billion in 2031.

Biotechnology Contract Manufacturing Market Size, Share, Report 2031

Global Biotechnology Contract Manufacturing Market Assessment, Opportunities and Forecast, 2017-2031F

Global biotechnology contract manufacturing market is expected to experience rapid growth due to the growing demand for biopharmaceuticals, technical advancements in cell and gene therapies, and advancements in manufacturing technologies.

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics